Clinical significance of retinal emboli during diagnostic and therapeutic cardiac catheterization in patients with coronary artery disease
© Kojuri et al; licensee BioMed Central Ltd. 2011
Received: 14 July 2010
Accepted: 21 January 2011
Published: 21 January 2011
Cardiac catheterization may cause retinal embolization, a risk factor for cerebrovascular emboli and stroke. We describe the incidence of clinically silent and apparent retinal emboli following diagnostic and interventional coronary catheterization and associated risk factors.
Three hundred selected patients attending a tertiary referral center for diagnostic and therapeutic cardiac catheterization were studied. Retinal examination and examination of the visual field and acuity were done before and after catheterization by a retinal specialist.
There were 5 case of retinal embolus before catheterization, and 19 patients (incidence 6.3%) developed new retinal arteriolar emboli after catheterization. Only 1 patient developed clinically apparent changes in vision. Two conventional risk factors (age and hypertension) were significantly associated with new retinal emboli. The risk of retinal emboli was also significantly associated with operator expertise.
Retinal embolism was found after coronary catheterization in 6.3% of our patients. This finding indicates that the retinal, and possibly the cerebral circulation, may be compromised more frequently than is clinically apparent as a complication of coronary catheterization. Age and hypertension are independent predictors of retinal embolism.
Coronary atherosclerosis is the leading cause of death and disability in the developed world. Coronary angiography and angioplasty are currently the standard procedures for the diagnosis and treatment of coronary artery disease. However, these procedures are invasive and involve a risk of complications such as vascular and hemodynamic complications, contrast-related reactions, arrhythmia and myocardial infarction . Moreover, because of the many opportunities for air, clots, or solid particles to enter the systemic circulation, embolism is one of the most serious complications associated with coronary catheterization . The origins of systemic emboli are varied and include atheromatous emboli, cholesterol emboli (from ulcerated plaques), thrombus formation at the catheter tip [3, 4], air embolism [5, 6] and rarely, foreign materials from the catheter or guide wire .
Cholesterol emboli during catheterization are thought to be caused by the disruption of a vascular plaque (mainly by catheter manipulation) with the release of subendothelial cholesterol crystals into the blood stream . One of the most dangerous consequences of cholesterol emboli is central nervous system (CNS) emboli, which can result in stroke, a rare but serious complication of cardiac catheterization [1, 9]. The risk of clinically apparent stroke attributable to cardiac catheterization is reported to be between 0.11% and 0.38% ; however, a high incidence of post-catheterization asymptomatic cerebrovascular embolism (15%) was documented in a study that compared pre- and post- coronary catheterization brain magnetic resonance images . Another study showed a 10-fold increase in the incidence of stroke among men followed for a mean of 3.4 years after an index retinal embolus over the stroke incidence seen in a control group over the same period . It was also shown that persons with retinal emboli at baseline had an increased risk of dying of stroke compared to those without retinal emboli. After adjustment for systemic factors, a fatal stroke was about 3 times as likely in persons with retinal emboli during an 8-year period as in persons without retinal emboli .
The ophthalmic artery is the first major branch of the internal carotid artery and thus emboli from the heart and great vessels proximal to the carotid tend to directly go to the eye. Retinal arteriolar emboli are generally described as discrete plaque-like lesions in the lumen of the retinal arterioles or at bifurcations. They are composed of fibrin-platelet aggregates, cholesterol fragments, or particles of calcified valves. They originate predominately from an ulcerated atheromatous carotid artery or ascending aorta plaque, calcified aortic valves, or a mural internal carotid thrombus, and are classified as cholesterol (reflective or refractile), fibrin-platelet (dull or nonreflective) or calcific (chalky white) . Retinal emboli may be a simply detectable predictor of CNS embolism. Previous studies have reported rates of retinal emboli between 55% and 100% after bypass surgery, and 1.25% and 13.2% after carotid stenting [14–16]. The rate of retinal emboli after cardiac catheterization is still controversial. Peri-coronary catheterization retinal emboli occur during or immediately after the procedure, when the femoral artery sheath is still in place . Retinal cholesterol emboli, known as Hollenhorst plaques, have a distinctive focal bright, refractive yellow-orange appearance . Retinal emboli are partially obstructive and asymptomatic most of the time ; however, central retinal occlusion, although rare, is an emergency situation whose treatment remains highly uncertain and controversial . Some treatments such as intravenous mannitol or beta-blockers and oral acetazolamide do not appear to be fully effective. An experimental study of central retinal artery occlusion showed that occlusion lasting about 97 min resulted in massive, irreversible damage. Thus, no treatment instituted much longer than 1.5 hours after the onset can be expected to restore vision [19–21].
We aimed to assess the incidence of acute retinal embolism after coronary catheterization. In addition, we sought possible risk factors that may increase the possibility of this complication.
From February 2009 to March 2010, 300 patients who underwent diagnostic (n = 150) or therapeutic coronary catheterization (n = 150) were included in our study. There were 156 men and 144 women, and mean age was 59.36 ± 7.86 years. Exclusion criteria were arrhythmia (especially atrial fibrillation), significant valvular heart disease confirmed by transthoracic echocardiography, and peripheral vascular disease. Patients with minor coronary artery disease (stenosis less than 50%) were excluded from the study. Written informed consent was obtained from all patients, and the study was approved by the research ethic committee of the Shiraz University of Medical Sciences and Kowsar Hospital.
Complete medical history and findings on physical examination were documented for each patient, and cardiovascular risk factors such as dyslipidemia, diabetes mellitus, smoking, hypertension, and obesity were recorded. Procedural data (i.e., use of balloon, size of stent, fluoroscopy time and the total duration of the procedure excluding fluoroscopy time) were recorded. The number of occluded vessels and degree of stenosis were recorded.
Coronary catheterization via a femoral access point was performed by 5 experienced cardiologists, each with at least 4 years of experience in cardiac catheterization. In all patients who underwent diagnostic angiography, standard coronary angiography was done according to the Seldinger method, with a 6F catheter and guide wire. No heparin was given for diagnostic angiography. For percutaneous transluminal coronary angioplasty with stent implantation with or without balloon dilation, a 6F or 7F catheter was used. These patients were given 10 000 international units of heparin as a bolus to maintain an activated clotting time of more than 250 s, and received at least 360 mg aspirin and 600 mg clopidogrel bisulfate before the angioplasty. A standard nonionic contrast medium (Omnipaque or Visipaque, GE, Buckinghamshire, UK or Ultrvist, Bayer HealthCare Pharmaceuticals, Leverkusen, Germany) was used. For diagnostic angiography, sheaths were removed immediately after the procedure. In patients who underwent therapeutic catheterization, the sheaths were removed 6 h after the procedure.
One day before the procedure, visual acuity was determined with the Snellen chart and visual field was measured with the confrontation test and subjective history. The visual field and visual acuity were checked again 24 h after the procedure. Retinas were examined by a retinal subspecialist. Pre-catheterization (median 19 h, range 13-25 h) and post-catheterization examinations (45 h, 17-96 h) were done by a retinal specialist after pupil dilation with 1.0% tropicamide. The macula and posterior pole were examined with a 78D non-contact lens through a slit lamp, and indirect ophthalmoscopy with a Volk 2.2D lens was done to visualize the peripheral portions of retina. We did not use digital retinal photography because this technique cannot visualize the retina beyond 60 degrees, so small peripheral emboli would be missed.
For statistical analyses, the patients were classified into two groups: those with and those without retinal emboli. For categorical and noncategorical variables, we used the chi-squared test to determine whether differences between groups were significant. A P value < 0.05 was considered significant.
Final study population
Of the 408 patients initially recruited, cardiac catheterization was performed in 406, but only 300 patients attended their post-catheterization eye examination. Twenty patients had normal angiograms or mild coronary artery disease, and the others refused further cooperation. Therefore, this report is based on statistical analysis of the data for 300 patients (mean age 59.36 ± 7.86 years, 156 men and 144 women).
Characteristics of 300 patients in Shiraz, Iran, with and without new retinal emboli after cardiac intervention.
Normal (n = 281)
New lesions (n = 19)
59 ± 7.83
64.5 ± 6.16
Body mass index >30
Procedural risk factors, severity of coronary artery disease, and their relation to new retinal emboli in 300 patients in Shiraz, Iran.
Normal (n = 281)
New lesion (n = 19)
32.23 ± 13.8
32 ± 17.6
2.87 ± 0.34
2.65 ± 0.2
Balloon insertion before process
Duration of fluoroscopy
8.69 ± 3.94
8.26 ± 2.8
Duration of procedure
16.11 ± 4.7
19.21 ± 4.28
Retinal examination by the retinal specialist showed that 5 patients (1.7%) had prior retinal emboli: 3 in the angiography (diagnostic) group (2%) and 2 in the angioplasty (therapeutic) group (1.33%). All of them were cholesterol emboli. These numbers were too small for valid statistical comparison. Post-procedure retinal examination diagnosed a total of 19 new lesions (6.33%). Of these 19 patients, 8 had undergone cardiac catheterization for diagnostic purposes (5.33%) and the remaining 11 (7.33%) for therapy.
Visual field and acuity were tested within 24 h after catheterization. The findings of all post-procedure visual assessments were negative.
Our search for likely procedural risk factors failed to identify any potential relationship between risk factors and the appearance of retinal emboli. Although we observed, in this small series, a slightly higher incidence of retinal emboli in patients who underwent catheterization for therapy rather than diagnosis only, this difference was not significant (P = 0.477).
Fluoroscopy time and duration of the procedure
We found no significant difference in fluoroscopy time between patients with and without new retinal emboli (P = 0.871).
Of the clinical and procedural variables analyzed in our sample of 300 patients who underwent diagnostic or therapeutic catheterization, 2 conventional risk factors (age and hypertension) and operator expertise were strongly associated with the appearance of new retinal emboli. Other conventional and procedural risk factors showed no significant relation with the appearance of this lesion. At the start of the study, we hypothesized a strong association between the severity of coronary artery disease and the risk of retinal embolization. We reasoned that more severe coronary artery disease would be related with more atherosclerosis of the aorta, which in turn would make patients more susceptible to retinal emboli. As noted by Segal and colleagues, plaque broken off from the ascending aorta or the aortic arch can be the main source of systemic emboli including retinal lesions . It appears likely that the risk of vascular plaque mobilization increases with aging and hypertension.
Klein et al.  found that the prevalence of baseline retinal emboli was associated with higher pulse pressure, hypertension, cardiovascular disease, diabetes mellitus and past and current smoking. The prevalence of baseline retinal emboli in their patients was 1.3%. Our study identified some of the same risk factors, including age and hypertension, as playing a role in post-procedure retinal emboli. A prospective cohort study by Thyer et al.  found a prevalence of baseline retinal emboli of 5%, but obtained no evidence suggesting that coronary catheterization contributes to retinal embolism shortly after the procedure. Funduscopic examination detected no new retinal emboli in 97 patients who underwent coronary catheterization. The differences between their findings and ours may have arisen, in part, because Thyer and colleagues included patients with a normal angiogram in their sample of patients who underwent coronary catheterization, and their sample was too small to reveal significant differences.
Kreis et al.  found a 2% incidence of acute retinal embolism after coronary catheterization, and indicated that the retinal and possibly cerebral circulation may be more severely compromised more frequently than is clinically apparent. In their study the main method of retinal examination was digital retinal photography. New retinal emboli after cardiac catheterization were seen in 6.3% of our patients. The reason for our higher figure compared to the incidence found by Kreis and colleagues may be that routine retinal photography is not sensitive enough to detect tiny retinal emboli that cause partial, peripheral arteriolar obstruction.
Busing et al.  found that diagnostic and interventional cardiac catheterization increased the risk of silent cerebral infarction to 15%. Their sample of 48 patients was not large enough to analyze risk factors, and they noted that the statistical analysis of their results was weak, so they could not evaluate potential risk factors in detail.
Our figures for the incidence of retinal emboli after coronary catheterization are based on the findings of retinal examination by a retinal specialist. Nineteen patients developed retinal emboli, only one of which was clinically apparent. With regard to the rate of emboli formation and their clinical significance, cardiac catheterization can be considered a safe procedure. In our patients, all lesions were located in non-eloquent areas of the retina (one was found in the main branch of the central retinal artery) and were too small to be clinically apparent. However, when lesions affect more important areas of the retina, such as the central retinal artery, they can have severe clinical consequences. Cardiologists who perform coronary catheterization should be cognizant of the clinical symptoms and signs of large retinal emboli (i.e., any visual complaint, especially a decrease in visual field or acuity), because they can have a devastating effect on the retina. Because coronary catheterization may contribute to retinal artery occlusion, prompt consultation with an ophthalmologist should be considered if symptoms suggestive of visual disturbance appear during or soon after coronary catheterization.
The rate of retinal embolization appeared to be slightly higher after therapeutic cardiac catheterization than after diagnostic angiography; however, this difference was not statistically significant. We suspect that further manipulation of the aortic root might increase the risk of embolism, and further research will be needed to test this hypothesis. Retinal emboli occurring after cardiac catheterization warrant a careful vascular workup including a search for the emboli in the aortic arch, the great vessels and the chambers of the heart itself. Vascular ultrasound, transesophageal echocardiography and (potentially) computed tomographic angiography or magnetic resonance angiography can be extremely useful in this regard. These techniques, unfortunately, were not available at our center when we studied this cohort.
Our findings in a selected cohort of patients suggest that cardiac catheterization is safe and feasible. Retinal emboli are generally clinically silent and do not produce any visual sequelae; however, age and hypertension are independent predictors of retinal emboli.
We thank the Shiraz University of Medical Sciences Research Faculty for financial support, and the Kowsar Hospital Research Committee for its support. We also thank K. Shashok (AuthorAID in the Eastern Mediterranean) for improving the language and organization of the manuscript.
- Sankaranarayanan R, Msairi A, Davis GK: Stroke complicating cardiac catheterization - A preventable and treatable complication. Ann Intern Med. 1996, 122: 249-253.Google Scholar
- Inoue H, Muneuchi J, Ohno T, Arikawa A, Ishibashi T, Hara T: Central retinal artery occlusion following transcatheter balloon aortic valvuloplasty in an adolescent with aortic valvular stenosis. Pediatr Cardiol. 2008, 29: 830-833. 10.1007/s00246-007-9181-0.View ArticlePubMedGoogle Scholar
- Segal AZ, Abernethy WB, Palacios IF, Belue R, Rodorf G: Stroke as a complication of cardiac catheterization: risk factors and clinical features. Neurology. 2001, 56: 975-7.View ArticlePubMedGoogle Scholar
- Bendszus M, Koltzenburg M, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L: Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study. Lancet. 1999, 354: 1594-7. 10.1016/S0140-6736(99)07083-X.View ArticlePubMedGoogle Scholar
- Wijman CA, Kase CS, Jacobs AK, Whitehead RE: Cerebral embolism as a cause of stroke during cardiac catheterization. Neurology. 1998, 51: 318-9.View ArticlePubMedGoogle Scholar
- Stygall J, Kong R, Walker JM, Hardman SM, Harrison MJ, Newman SP: Cerebral microembolism detected by transcranial Doppler during cardiac procedures. Stroke. 2000, 31: 2508-10.View ArticlePubMedGoogle Scholar
- Jassal DS, Fast MD, McGinn G: Multifocal brain MRI hypointensities secondary to cardiac catheterization. Neurology. 2000, 54: 2023-4.View ArticlePubMedGoogle Scholar
- Bashore TM, Gehrig T: Cholesterol emboli after invasive cardiac procedures. Am Coll Cardiol. 2003, 42: 217-8. 10.1016/S0735-1097(03)00587-4.View ArticleGoogle Scholar
- Khatri P, Taylor RA, Palumbo V, Rajajee V, Katz JM, Chalela JA: The safety and efficacy of thrombolysis for strokes after cardiac catheterization. 2008, 51: 906-11.Google Scholar
- Busing KA, Schulte-Sasse C, Fluchter S, Suselbeck T, Hause KK, Neff W, Hirschg G, Brogrrefe M, Duber G: Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization-prospective evaluation at diffuse weighted MRI. Radiology. 2005, 235: 177-183. 10.1148/radiol.2351040117.View ArticlePubMedGoogle Scholar
- Bruno A, Jones WL, Austin JK, Carter S, Qualls C: Vascular outcome in men with asymptomatic retinal cholesterol emboli: a cohort study. Ann Intern Med. 1995, 122: 249-253.View ArticlePubMedGoogle Scholar
- Klein R, Klein BE, Moss SE, Meuer SM: Retinal emboli and stroke. Arch Ophthalmol. 1999, 117: 1063-8.View ArticlePubMedGoogle Scholar
- Baker ML, Hand PJ, Wang JJ, Wong TY: Retinal signs and stroke: revisiting the link between the eye and brain. Stroke. 2008, 39: 1371-1379. 10.1161/STROKEAHA.107.496091.View ArticlePubMedGoogle Scholar
- Ascione R, Ghosh A, Reeves BC, Arnold J, Potts M, Shah A, Angelini GD: Retinal and cerebral microembolization during coronary artery bypass surgery: a randomized, controlled trial. Circulation. 2005, 112: 3833-3838. 10.1161/CIRCULATIONAHA.105.557462.View ArticlePubMedGoogle Scholar
- Blauth C, Arnold J, Kohner EM, Taylor KM: Retinal microembolism during cardiopulmonary bypass demonstrated by fluorescein angiography. Lancet. 1986, 2: 837-839. 10.1016/S0140-6736(86)92871-0.View ArticlePubMedGoogle Scholar
- Wilentz JR, Chati Z, Krafft V, Amor M: Retinal embolization during carotid angioplasty and stenting: mechanisms and role of cerebral protection systems. Catheter Cardiovasc Interv. 2002, 56: 320-327. 10.1002/ccd.10232.View ArticlePubMedGoogle Scholar
- Eser I: Retinal artery occlusions of cardiac origin, A retrospective review. Etiology and screening. J Card Res. 2007, 7: 123-8.Google Scholar
- Gordham A, Ray W: Retinal cholesterol embolism and visual loss post carotid angioplasty and stenting. Am J Case Rep . 2008, 9: 159-162. [http://www.amjcaserep.com]Google Scholar
- Nakata A, Seciguchi Y, Hirota S, Yamashita Y, Takazakura E: Central retinal artery occlusion following cardiac catheterization. Jpn Heart J. 2002, 43: 187-192. 10.1536/jhj.43.187.View ArticlePubMedGoogle Scholar
- Zhang Y, Cho CH, Atchaneeyasakul LO, McFarland T, Appukuttan B, Stout T: Activation of the mitochondrial apoptotic pathway in a rat model of a central retinal artery occlusion. IOVC. 2005, 46: 2133-2139.Google Scholar
- O'Malley E, Lee AG: Central Retinal Artery Occlusion (CRAO): 81 year old white man with sudden painless vision loss OS. 2005, [http://www.eyerounds.org/cases/case20.htm]Google Scholar
- Thyer I, Kovoor P, Wang JJ, Taylor B, Kifley A, Lindley R: Coronary catheterization does not lead to retinal artery in short term follow-up of cardiac patients. Stroke. 2007, 38: 2370-10.1161/STROKEAHA.107.483214.View ArticlePubMedGoogle Scholar
- Kreis AJ, Nguyen T, Rogers S, Wang JJ, Harper CA: Acute retinal arteriolar emboli after cardiac catheterization. Stroke. 2008, 39 (11): 3086-7. 10.1161/STROKEAHA.108.516591.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2261/11/5/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.